Sutro Biopharma, Inc. (STRO) Stock Forecast
Data as of Aug 5, 2026Healthcare · Current price $25.80 (+2.79%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
STRO vs Sector & Market
| Metric | STRO | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.25 | 2.42 |
| Analyst Count | 8 | 8 | 18 |
| Target Upside | +112.5% | +16316.0% | +17.1% |
| P/E Ratio | -1.56 | 3.33 | 36.31 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $6M | $8M | $11M | 4 |
| 2026-12-31 | $6M | $8M | $11M | 4 |
| 2027-03-31 | $1M | $2M | $3M | 4 |
| 2027-06-30 | $12M | $17M | $22M | 3 |
| 2027-09-30 | $13M | $18M | $24M | 3 |
| 2027-12-31 | $13M | $19M | $25M | 3 |
| 2028-12-31 | $11M | $38M | $67M | 7 |
| 2029-12-31 | $15M | $55M | $97M | 3 |
| 2030-12-31 | $20M | $71M | $125M | 6 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $-3.72 | $-2.66 | $-1.60 | 3 |
| 2026-12-31 | $-3.55 | $-2.54 | $-1.52 | 3 |
| 2027-03-31 | $-3.21 | $-2.30 | $-1.38 | 3 |
| 2027-06-30 | $-3.11 | $-2.23 | $-1.34 | 2 |
| 2027-09-30 | $-3.08 | $-2.20 | $-1.32 | 2 |
| 2027-12-31 | $-2.76 | $-1.97 | $-1.18 | 2 |
| 2028-12-31 | $-14.11 | $-7.93 | $-1.73 | 6 |
| 2029-12-31 | $-14.75 | $-7.44 | $-0.45 | 4 |
| 2030-12-31 | $-12.14 | $-6.12 | $-0.37 | 2 |
Frequently Asked Questions
What is the analyst consensus for STRO?
The consensus among 8 analysts covering Sutro Biopharma, Inc. (STRO) is Buy with an average price target of $50.75.
What is the highest price target for STRO?
The highest analyst price target for STRO is $60.00.
What is the lowest price target for STRO?
The lowest analyst price target for STRO is $43.00.
How many analysts cover STRO?
8 analysts have issued ratings for Sutro Biopharma, Inc. in the past 12 months.
Is STRO a buy or sell right now?
Based on 8 analyst ratings, STRO has a consensus rating of Buy (2.00/5) with a +112.5% upside to the consensus target of $50.75.
What are the earnings estimates for STRO?
Analysts estimate STRO will report EPS of $-2.66 for the period ending 2026-09-30, with revenue estimated at $8M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.